Aflac Incorporated

The thesis was fundamentally a survival/resilience call: Aflac's strong capital position and conservative investment strategy would let it weather market challenges despite balance sheet pressures. That core claim was validated — Aflac remained solvent, stayed profitable, and continued operating as a major insurer through the stressed period, without the capital impairment skeptics feared. However, since no price performance or elapsed time is provided, the return component of the long thesis cannot be verified, so confidence is low.